D L Dries

Summary

Publications

  1. ncbi Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventric
    D L Dries
    Clinical Trials Scientific Research Group, The National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    J Am Coll Cardiol 32:695-703. 1998
  2. ncbi Racial differences in the outcome of left ventricular dysfunction
    D L Dries
    Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Application, National Heart, Lung, and Blood Institute, Bethesda, MD 20892 7936, USA
    N Engl J Med 340:609-16. 1999
  3. ncbi Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
    D V Exner
    Clinical Trials Scientific Research Group, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    J Am Coll Cardiol 33:916-23. 1999
  4. ncbi Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials
    D L Dries
    Clinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892 7936, USA
    J Am Coll Cardiol 29:1074-80. 1997
  5. ncbi Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction
    H A Cooper
    Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
    Circulation 100:1311-5. 1999

Detail Information

Publications5

  1. ncbi Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventric
    D L Dries
    Clinical Trials Scientific Research Group, The National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    J Am Coll Cardiol 32:695-703. 1998
    ....
  2. ncbi Racial differences in the outcome of left ventricular dysfunction
    D L Dries
    Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Application, National Heart, Lung, and Blood Institute, Bethesda, MD 20892 7936, USA
    N Engl J Med 340:609-16. 1999
    ..Although these factors probably account for some of the higher mortality due to congestive heart failure among blacks, we hypothesized that racial differences in the natural history of left ventricular dysfunction might also have a role...
  3. ncbi Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
    D V Exner
    Clinical Trials Scientific Research Group, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    J Am Coll Cardiol 33:916-23. 1999
    ....
  4. ncbi Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials
    D L Dries
    Clinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892 7936, USA
    J Am Coll Cardiol 29:1074-80. 1997
    ....
  5. ncbi Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction
    H A Cooper
    Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
    Circulation 100:1311-5. 1999
    ..These data suggest that diuretic-induced electrolyte disturbances may result in fatal arrhythmias in patients with systolic left ventricular dysfunction...